Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Epidermal growth factor receptor kinase substrate 8-like protein 2 (EPS8L2) is a cytoplasmic adaptor and actin-binding protein belonging to the EPS8 family, characterized by its modular structure with actin-binding and SH3 domains. EPS8L2 is predominantly expressed in the tips of hair cell stereocilia, where it plays a key role in the long-term maintenance and integrity of the stereociliary structure essential for mechanotransduction in hearing. Mutations or loss of function in EPS8L2 are linked to progressive and late-onset hearing loss due to gradual deterioration of hair bundle morphology. EPS8L2 is biochemically and functionally related to EPS8, with partial functional redundancy; it contributes to receptor tyrosine kinase signaling cascades that regulate actin remodeling but is not known to be a direct target of approved drugs or components of well-defined targeted therapeutic mechanisms[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Epidermal growth factor receptor kinase substrate 8-like protein 2 (EPS8L2).